Program Highlight

UIHC Ethics Consult Service
The Ethics Consult Service is a resource for patients, family members, or health professionals at UIHC who would like help addressing an ethical question or problem related to a patient's care.
Ethics consults are advisory and can be requested to:
• Identify ethical problems in the care of a patient Biobanks face unique challenges obtaining consent from biospecimen contributors. Electronic consent (e-consent) presents one option for streamlining the biobank consent process, and improving contributor understanding of consent information. An email survey was conducted to establish the extent of current biobank e-consent and interest in future use of e-consent. A total of 235 biobanks were surveyed and 65 (28%) responded with a fully completed survey. Few of these 65 biobanks (8%) reported using econsent; however, the majority (75%) were interested in e-consent. Many (48%) biobanks were in discussions with institutional stakeholders about using e-consent in the future. Anticipated benefits of e-consent included improved efficiency and increased enrollment. Perceived barriers to e-consent adoption included lack of funding, issues with human subjects approval, and factors affecting user uptake (e.g., computer literacy). Biobanks using e-consent reported cost, technology issues, and difficulty training staff as barriers to e-consent adoption. Traditional consenting methods (e.g., face-to-face, phone, and mail) continued to be used at biobanks reporting use of e-consent. The survey results suggest strong interest in e-consent among U.S. biobanks, and a need to consider a range of implementation issues, including user preferences and receptivity; institutional and technical support; integration with clinical data networks; electronic signature capture; and what type of econsent to implement. Biobanks will need evidence-based guidance for purposes of addressing these issues, so that e-consent processes enhance efficiency, as well as contributor receptivity, understanding, and trust.
Clinical Research Ethics Consultation Service
We provide free consultation on ethical issues related to research design, tissue banking, genetic research results, informed consent, and working with vulnerable patient populations. In particular, we assist clinical investigators in identifying and addressing the ethical challenges that frequently arise when designing or conducting research with human subjects. These include ethical challenges in sampling design; randomized and placebocontrolled studies; participant recruitment and informed consent; return of individuallevel research results; community engagement processes; and more. For more information, please click here.
Resource Highlight Iowa Physician Orders for Scope of Treatment (IPOST)
The Iowa Physician Orders for Scope of Treatment, known as IPOST, is a double-sided, one-page, salmon-colored document that allows a patient to communicate their preferences for key lifesustaining treatments including: cardio-pulmonary resuscitation, general scope of treatment, artificial nutrition and more. IPOST is appropriate for: (1) the chronically, seriously ill individual frequently visiting healthcare facilities; (2) an individual with a life-limiting illness; and (3) frail and elderly individuals. Chapter 144D of the Iowa Code is the Iowa legislative law pertaining to the IPOST form. The Iowa Code states that the IPOST form: (1) is a standardized form that is easily recognizable; (2) will be placed in the front of the patient's medical chart, when admitted; (3) belongs to the patient and will transfer with the patient from one healthcare setting to another; and (4) can be voided or updated if the patient's treatment preferences change.
IPOST Mission:
To promote community care coordination and advance care planning.
IPOST Vision: Seamless communication and execution of individual patient care choices across the healthcare continuum.
To download the IPOST form and guidelines for using the IPOST form, please click here.
